VRXAW
Veraxa Biotech AG WarrantsUS
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
—
52W High
$0.35
52W Low
$0.11
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Veraxa Biotech AG Warrants
Veraxa Biotech AG Warrants (VRXAW) is a biotechnology firm specializing in the development of innovative therapies through advanced biotechnological processes. The company seeks to address unmet medical needs by focusing on novel drug candidates aimed at various therapeutic areas. With a robust pipeline and a commitment to rigorous research and development, Veraxa Biotech is strategically positioned to leverage its proprietary technologies for the advancement of healthcare solutions. As an investment opportunity, it holds potential for growth driven by its scientific advancements and collaborations within the biotech landscape.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Data last updated: 7/9/2026